Search Clinical Trials
585,889 trials
ID
Status
Phase
Title
Sponsor
NCT07604883
Early Molecular Biomarkers for Differentiating Parkinsonian SyndromesInternational Institute of Molecular and Cell Biology in WarsawNot Yet Recruiting
NCT07604883Not Yet Recruiting
—
Early Molecular Biomarkers for Differentiating Parkinsonian SyndromesInternational Institute o...
NCT07603765
Minimally Invasive Hemodynamic Monitoring in Cardiac AblationIstanbul University - CerrahpasaRecruiting
NCT07603765Recruiting
—
Minimally Invasive Hemodynamic Monitoring in Cardiac AblationIstanbul University - Cer...
NCT07601009
Validity and Reliability of a Mixed Reality-Based 6-Minute Walk TestSelcuk UniversityRecruiting
NCT07601009Recruiting
—
Validity and Reliability of a Mixed Reality-Based 6-Minute Walk TestSelcuk University
NCT07605234
Phase II Single Arm Open Label Study Evaluating the Feasibility and Safety of Photobiomodulation as an Adjunct to Standard Supportive Care for Chemotherapy Induced Oral Mucositis in Pediatric Patients With Hematolymphoid MalignanciesTata Memorial HospitalNot Yet RecruitingNot Applicable
NCT07605234Not Yet Recruiting
Not Applicable
Phase II Single Arm Open Label Study Evaluating the Feasibility and Safety of Ph...Tata Memorial Hospital
NCT07601997
Safety and Feasibility of Transcatheter Injectable Hydrogel in Acute STEMI Reperfusion Injury (REFINE Study)Myomed Technology (Shaoxing) Co., Ltd.Not Yet RecruitingNot Applicable
NCT07601997Not Yet Recruiting
Not Applicable
Safety and Feasibility of Transcatheter Injectable Hydrogel in Acute STEMI Reper...Myomed Technology (Shaoxi...
NCT07602530
A Study in Canada to Follow Outcomes of Women in Menopause Treated With Fezolinetant for Hot Flashes, When Given in Clinical PracticeAstellas Pharma Europe Ltd.Recruiting
NCT07602530Recruiting
—
A Study in Canada to Follow Outcomes of Women in Menopause Treated With Fezoline...Astellas Pharma Europe Lt...
NCT07602426
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of resO™ Bone and Joint Support Postbiotic on Physical Function, Pain Interference, and Mobility in Adults With Joint DiscomfortAble Biolabs, LLCActive Not RecruitingNot Applicable
NCT07602426Active Not Recruiting
Not Applicable
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of...Able Biolabs, LLC
NCT07601295
Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)National Heart, Lung, and Blood Institute (NHLBI)Not Yet RecruitingPhase 2
NCT07601295Not Yet Recruiting
Phase 2
Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of P...National Heart, Lung, and...
NCT07602699
Multi-Site Trial of Tirzepatide for Smoking CessationNational Institute on Drug Abuse (NIDA)RecruitingPhase 2
NCT07602699Recruiting
Phase 2
Multi-Site Trial of Tirzepatide for Smoking CessationNational Institute on Dru...
NCT07601854
Elucidating the Neural Correlates of Anesthesia-induced Unconsciousness in NeonatesPontificia Universidad Catolica de ChileNot Yet Recruiting
NCT07601854Not Yet Recruiting
—
Elucidating the Neural Correlates of Anesthesia-induced Unconsciousness in Neona...Pontificia Universidad Ca...
NCT07605299
"Comparative Effect of Rolfing Soft Tissue Manipulation and Bowen Technique on Calf Tightness Among Housewives"Rashid Latif Medical CollegeCompletedNot Applicable
NCT07605299Completed
Not Applicable
"Comparative Effect of Rolfing Soft Tissue Manipulation and Bowen Technique on C...Rashid Latif Medical Coll...
NCT07604038
Oral Supplementation With 1 mg of KGA-10 Daily (a Novel Environmentally-derived Mycolicibacterium) for Stress, Sleep, and InflammationKioga Inc.CompletedNot Applicable
NCT07604038Completed
Not Applicable
Oral Supplementation With 1 mg of KGA-10 Daily (a Novel Environmentally-derived...Kioga Inc.
NCT07603050
A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of VGN-R08b in Patients With Type III Gaucher's DiseaseShanghai Vitalgen BioPharma Co., Ltd.Not Yet RecruitingPhase 1
NCT07603050Not Yet Recruiting
Phase 1
A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of VGN-R08b in P...Shanghai Vitalgen BioPhar...
NCT07603232
Long-Term Health Outcomes in Children Born With Hirschsprung's Disease and Anorectal Malformations at the Colorectal Centre of Excellence in QuebecMcGill University Health Centre/Research Institute of the McGill University Health CentreEnrolling By Invitation
NCT07603232Enrolling By Invitation
—
Long-Term Health Outcomes in Children Born With Hirschsprung's Disease and Anore...McGill University Health...
NCT07604623
Recurrent Laryngeal Nerve Monitoring During Pediatric Aerodigestive Tract and Cardiac SurgeryUniversity of AlbertaNot Yet RecruitingNot Applicable
NCT07604623Not Yet Recruiting
Not Applicable
Recurrent Laryngeal Nerve Monitoring During Pediatric Aerodigestive Tract and Ca...University of Alberta
NCT07604025
Senna vs. Polyethylene Glycol 3350 for the Treatment of Retentive Encopresis in Children: a Randomized, Double-blinded, StudyAssaf-Harofeh Medical CenterNot Yet RecruitingEarly Phase 1
NCT07604025Not Yet Recruiting
Early Phase 1
Senna vs. Polyethylene Glycol 3350 for the Treatment of Retentive Encopresis in...Assaf-Harofeh Medical Cen...
NCT07601048
A Trial of HRS-7058 in Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard TreatmentShandong Suncadia Medicine Co., Ltd.Not Yet RecruitingPhase 3
NCT07601048Not Yet Recruiting
Phase 3
A Trial of HRS-7058 in Advanced or Metastatic Non-Small Cell Lung Cancer Patient...Shandong Suncadia Medicin...
NCT07604363
High-Fidelity Simulation and Longitudinal Outcomes in Novice Nurses (HFS-NOVA)Tri-Service General HospitalCompletedNot Applicable
NCT07604363Completed
Not Applicable
High-Fidelity Simulation and Longitudinal Outcomes in Novice Nurses (HFS-NOVA)Tri-Service General Hospi...
Result Breakdown
Not yet recruiting10 (50%)
Recruiting4 (20%)
Completed4 (20%)
Active, not recruiting1 (5%)
Enrolling by invitation1 (5%)
not_applicable9 (45%)
Not Specified6 (30%)
Phase 22 (10%)
Phase 11 (5%)
Early Phase 11 (5%)
Phase 31 (5%)